These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34825870)

  • 21. The role of N6-methyladenosine (m6A) in eye diseases.
    Gao JF; Zhang L
    Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of N6-Methyladenosine (m
    Qu N; Bo X; Li B; Ma L; Wang F; Zheng Q; Xiao X; Huang F; Shi Y; Zhang X
    Front Oncol; 2021; 11():755206. PubMed ID: 34692544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.
    Xu Z; Lv B; Qin Y; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
    He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
    Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of RNA methylation by means of N
    Wang S; Sun C; Li J; Zhang E; Ma Z; Xu W; Li H; Qiu M; Xu Y; Xia W; Xu L; Yin R
    Cancer Lett; 2017 Nov; 408():112-120. PubMed ID: 28867248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Connecting the Dots: N6-Methyladenosine (m
    Zhang M; Nie J; Chen Y; Li X; Chen H
    Adv Biol (Weinh); 2023 Aug; 7(8):e2300068. PubMed ID: 37353958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of m6A RNA methylation in the development of hepatitis B virus-associated hepatocellular carcinoma.
    Zhang C; Dai D; Zhang W; Yang W; Guo Y; Wei Q
    J Gastroenterol Hepatol; 2022 Nov; 37(11):2039-2050. PubMed ID: 36066844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
    Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA m
    Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
    EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The momentous role of N6-methyladenosine in lung cancer.
    Xu R; Pang G; Zhao Q; Yang L; Chen S; Jiang L; Shen Y; Shao W
    J Cell Physiol; 2021 May; 236(5):3244-3256. PubMed ID: 33135190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
    Liao Y; Han P; Zhang Y; Ni B
    Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Function and evolution of RNA N6-methyladenosine modification.
    Zhu ZM; Huo FC; Pei DS
    Int J Biol Sci; 2020; 16(11):1929-1940. PubMed ID: 32398960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
    Zou Y; Jiang G; Xie Y; Li H
    Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of N6-methyladenosine with viruses and virally induced diseases.
    Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1184-1201. PubMed ID: 32114429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated N6-methyladenosine (m
    Wang YF; Ge CM; Yin HZ; Dai ZH; Dong JP; Ji M; Yang F
    Ann Hepatol; 2021; 25():100538. PubMed ID: 34555511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival.
    Li Y; Qi D; Zhu B; Ye X
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.